BLT 0.00% 2.6¢ benitec biopharma limited

strategy

  1. 2,326 Posts.
    lightbulb Created with Sketch. 12
    how about benitec take one of these successfully completed in vivo studies by the Chinese, such as the lung cancer one, and pitch a licence deal at them for commercialisation - at a discount as required to get the ball rolling, and bring in some interest and possibly cash to charge the in house work.

    Might even set off a slight wave of anxiety amoungst the hesitating Western big pharma.

 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.